Clinical Trial Update: Ibrutinib, Rituximab, and Consolidation Chemotherapy in Treating Young Patients With Newly Diagnosed Mantle Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating ibrutinib in combination with rituximab and consolidation chemotherapy for young patients with newly diagnosed mantle c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• IMBRUVICA (IBRUTINIB)
• Rituxan (rituximab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Blastoid Variant Mantle Cell Lymphoma, Mantle Cell Lymphoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING